Viewing Study NCT03356860


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-01-06 @ 6:08 AM
Study NCT ID: NCT03356860
Status: COMPLETED
Last Update Posted: 2024-11-20
First Post: 2017-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.
Sponsor: Grand Hôpital de Charleroi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module